Treating ovarian cancers with PARP inhibitors
Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA
8 May 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in...
Dr James Gulley - National Cancer Institute, Bethesda, USA
15 Apr 2019
Using T cell engineering plus triple checkpoint blockade to enhance the efficacy...
Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA
15 Apr 2019
Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-...
Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands
15 Apr 2019
Gynaecological cancer: Where are we now?
Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
21 Mar 2019
Innovating India: Rural healthcare in Salboni
28 Feb 2019
BGICC 2019
28 Jan 2019
Can we cure cervical cancer?
Prof Murat Gultekin - Hacettepe University, Ankara, Turkey
28 Jan 2019
New FIGO staging in vulval and cervical cancer
Prof Sean Kehoe - University of Birmingham, Birmingham, UK
28 Jan 2019
Where does neoadjuvant chemotherapy in advanced ovarian cancer fit in clinical p...
Prof Sean Kehoe - University of Birmingham, Birmingham, UK
28 Jan 2019
Fertility issues during adjuvant treatment in premenopausal breast cancer patien...
Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy
25 Jan 2019
Pushing for cost effective interventions in lower and middle income countries
Prof Ophira Ginsburg - NYU Langone Health
26 Nov 2018
